Collegium Pharmaceutical
Price & Volume
Stats
See more52W Range | $23.23-$42.28 |
Market Cap | $1.1B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $707M |
Revenue Growth (YoY) | 29.4% |
Gross Profit (12 Mos) | $618.7M |
Diluted EPS | $1.06 |
News
See moreYahoo Finance • 2 months ago
Collegium Pharmaceutical Inc (NASDAQ:COLL) Reports Record Q2 2025 Earnings and Raises Full-Year Guidance
Yahoo Finance • 2 months ago
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook
Yahoo Finance • 3 months ago
Collegium Pharma Launches Up To $150 Mln Buyback Program; Stock Up In Pre-market
Yahoo Finance • 3 months ago
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
About
CEO | Mr. Vikram Karnani |
CFO | Ms. Colleen Tupper |
Address | 100 Technology Center Drive, Stoughton, MA, United States, 02072 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 357 |
